Allurion Technologies’ (ALUR) Neutral Rating Reaffirmed at Chardan Capital

Allurion Technologies (NYSE:ALUR)‘s stock had its “neutral” rating reaffirmed by stock analysts at Chardan Capital in a research report issued to clients and investors on Thursday,Benzinga reports.

ALUR has been the topic of several other research reports. Wall Street Zen lowered shares of Allurion Technologies from a “hold” rating to a “strong sell” rating in a research note on Saturday, August 16th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Allurion Technologies in a research note on Wednesday, October 8th. Finally, Zacks Research raised shares of Allurion Technologies to a “hold” rating in a report on Tuesday, August 12th. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $9.25.

Allurion Technologies Stock Down 9.0%

ALUR stock traded down $0.13 during trading on Thursday, hitting $1.27. The company had a trading volume of 134,362 shares, compared to its average volume of 938,477. The firm has a 50-day moving average price of $1.91 and a 200-day moving average price of $2.36. Allurion Technologies has a 12 month low of $1.25 and a 12 month high of $16.81. The stock has a market cap of $9.82 million, a price-to-earnings ratio of -0.12 and a beta of -0.46.

Allurion Technologies (NYSE:ALUR) last released its earnings results on Wednesday, November 12th. The company reported ($1.18) EPS for the quarter, beating the consensus estimate of ($2.45) by $1.27. The firm had revenue of $2.66 million during the quarter, compared to analyst estimates of $2.05 million. Equities analysts expect that Allurion Technologies will post -9.96 EPS for the current year.

Institutional Trading of Allurion Technologies

An institutional investor recently bought a new position in Allurion Technologies stock. XTX Topco Ltd bought a new position in shares of Allurion Technologies, Inc. (NYSE:ALUR) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund bought 13,037 shares of the company’s stock, valued at approximately $42,000. XTX Topco Ltd owned about 0.27% of Allurion Technologies at the end of the most recent quarter. 21.39% of the stock is currently owned by hedge funds and other institutional investors.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.